Classification
- Anatomical main groupGGenito-urinary system and sex hormones
- Therapeutic subgroupG03
- Pharmacological subgroupG03B
- Chemical subgroupG03BA
- Chemical substanceG03BA02Methyltestosterone
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 17 registrations
- Methyltestosterone10MG, 25MG, 5MG · tablet · Impax Labs
- Methyltestosterone10MG · capsule · Novitium Pharma
- Android 1010MG · tablet · Valeant Pharms North
- Android 2525MG · tablet · Bausch
Canada
Health Canada · 6 registrations
- Metandren 10MG10 MG / TAB · Tablet · Novartis Pharmaceuticals Canada INC
- Metandren 25MG25 MG / TAB · Tablet · Novartis Pharmaceuticals Canada INC
Taiwan
At a glance
- ATC code
- G03BA02
- Registers
- 4
- Registrations
- 27
- With their own page
- 17
- Companies
- 18
All medicines with Methyltestosterone
Human medicines from every register that match Methyltestosterone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
28 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Methyltestosterone | United States | 10MG, 25MG, 5MG | tablet | Marketed | Impax Labs |
| Methyltestosterone | United States | 10MG | capsule | Marketed | Novitium Pharma |
| Methyltestosterone | United States | 10MG, 25MG, 5MG | tablet | Not marketed | Tablicaps |
| Oreton Methyl | United States | 10MG, 25MG | tablet | Not marketed | Schering |
| Metandren | United States | 10MG, 25MG, 5MG | tablet | Not marketed | Novartis |
| Testred | United States | 10MG | capsule | Not marketed | Bausch |
| Android 10 | United States | 10MG | tablet | Not marketed | Valeant Pharms North |
| Android 25 | United States | 25MG | tablet | Not marketed | Bausch |
| Android 5 | United States | 5MG | tablet | Not marketed | Valeant Pharm Intl |
| Oreton | United States | 10MG | tablet | Not marketed | Schering |
| Virilon | United States | 10MG | capsule | Not marketed | Chartwell |
| Testosterone | United States | 30MG/1.5ML ACTUATION | solution, metered | Marketed | Cipla |
| Testosterone | United States | 1.62%, 10MG/0.5GM ACTUATION, 12.5MG/1.25GM ACTUATION | gel, metered | Marketed | Actavis Labs Ut INC |
| Testosterone | United States | 1.62%, 1.62%, 25MG/2.5GM PACKET … | gel | Marketed | Actavis Labs Ut INC |
| Testosterone | United States | 100MG/ML, 25MG/ML, 50MG/ML | injectable | Not marketed | Watson Labs |
| Esterified Estrogens and MethyltestosteroneCombination | United States | Status unknown | |||
| Esterified Estrogens and MethyltestosteroneCombination | United States | Status unknown | |||
| Esterified Estrogens and Methyltestosterone Half StrengthCombination | United States | Status unknown | |||
| Estratest HSCombination | United States | Status unknown | |||
| Estratest F.S.Combination | United States | Status unknown | |||
| Estratest H.S.Combination | United States | Status unknown | |||
| Vita Methyl Tostosterone Capsules "East Shine"Combination | Taiwan | 膠囊劑 | Cancelled | 久保製藥股份有限公司 | |
| Testosterone | United States | Status unknown | |||
| Testonus | Brazil | Cancelled | Profarb Ltda | ||
| Metandren 10MG | Canada | 10 MG / TAB | Tablet | Cancelled | Novartis Pharmaceuticals Canada INC |